2026-06-23 2026-06-23 , online online, 1,290 € zzgl. MwSt. Dr. Matthias Kühnle https://forum-institut.de/seminar/26112456-combination-products-from-cmc-and-quality-data-to-a-submission-ready-regulatory-dossier/referenten/26/26_11/26112456-pharma-seminar-combination-products-cmcquality-data_kuehnle-matthias.jpg Combination products: From CMC and quality data to a submission-ready regulatory dossier

The EU regulatory landscape for drug-device combination products is highly demanding. This seminar walks you through the regulatory landscape, from MDR, EU GMP, and ICH guidelines to marketing authorisation and conformity assessment, equipping you with practical strategies for building compliant, submission-ready dossiers.

Topics
  • Key guidelines and requirements (Focus: EU)
  • Marketing authorisation process for medicinal products
  • Conformity assessment of medical devices
  • Documentation strategy using quality related data as an example
  • Regulatory strategy and common pitfalls/solutions
  • Case studies/practical workshop


Who should attend
This seminar is designed for regulatory affairs and quality professionals working in the pharmaceutical, medical device, or combination product industry, particularly those involved in marketing authorisation, conformity assessment, or CMC documentation. It is equally valuable for product managers, project leads, and legal/compliance specialists who need a solid understanding of the regulatory frameworks governing drug-device combination products in the EU and beyond.
Aims and objectives
Drug-device combination products sit at the intersection of two highly complex regulatory worlds. Knowing how to navigate and combine the very different regulatory requirements for medicinal products and medical devices is becoming increasingly critical. In this seminar, you will gain a practice-oriented understanding of the EU regulatory landscape, from key guidelines and marketing authorisation to conformity assessment and documentation strategy. Through real-world case studies, you will learn how to structure compliant, submission-ready dossiers and confidently manage common pitfalls in your day-to-day work.
Your benefit

After having participated, you will be equipped with

  • a solid understanding of the EU regulatory framework for drug-device combination products, including MDR, EU GMP, and relevant ICH guidelines.
  • the ability to determine the primary mode of action (PMOA) and select the appropriate regulatory pathway for your product.
  • practical strategies for structuring compliant, submission-ready dossiers - and avoiding the most common pitfalls in your day-to-day work.

Pharma seminar - Combination products: CMC/quality data for the regulatory dossier

Combination products: From CMC and quality data to a submission-ready regulatory dossier

Practical preparation of compliant, sound documentation for drug- device combination products

Benefits
  • EU regulatory framework "demystified"
  • CMC & quality data mastered
  • Submission-ready dossier strategies
  • Real-world case studies included
  • Officially certified according to ISO 9001 and 21001

Webcode 26112456

Jetzt buchen

JETZT Buchen

Referenten


Alles auf einen Blick

Termin

24/11/2026

24/11/2026

Zeitraum

from 9:00 am to 5:00 pm CET - online training
You may dial in 30 minutes before the lecture starts

from 9:00 am to 5:00 pm CET - online training
You may dial in 30 minutes before the lecture starts
Veranstaltungsort

online

online

Gebühr
Your contact

Dr. Birgit Wessels
Conference Manager

+49 6221 500-652
b.wessels@forum-institut.de

Details

The EU regulatory landscape for drug-device combination products is highly demanding. This seminar walks you through the regulatory landscape, from MDR, EU GMP, and ICH guidelines to marketing authorisation and conformity assessment, equipping you with practical strategies for building compliant, submission-ready dossiers.

Topics

  • Key guidelines and requirements (Focus: EU)
  • Marketing authorisation process for medicinal products
  • Conformity assessment of medical devices
  • Documentation strategy using quality related data as an example
  • Regulatory strategy and common pitfalls/solutions
  • Case studies/practical workshop


Who should attend
This seminar is designed for regulatory affairs and quality professionals working in the pharmaceutical, medical device, or combination product industry, particularly those involved in marketing authorisation, conformity assessment, or CMC documentation. It is equally valuable for product managers, project leads, and legal/compliance specialists who need a solid understanding of the regulatory frameworks governing drug-device combination products in the EU and beyond.

Aims and objectives

Drug-device combination products sit at the intersection of two highly complex regulatory worlds. Knowing how to navigate and combine the very different regulatory requirements for medicinal products and medical devices is becoming increasingly critical. In this seminar, you will gain a practice-oriented understanding of the EU regulatory landscape, from key guidelines and marketing authorisation to conformity assessment and documentation strategy. Through real-world case studies, you will learn how to structure compliant, submission-ready dossiers and confidently manage common pitfalls in your day-to-day work.

Your benefit

After having participated, you will be equipped with

  • a solid understanding of the EU regulatory framework for drug-device combination products, including MDR, EU GMP, and relevant ICH guidelines.
  • the ability to determine the primary mode of action (PMOA) and select the appropriate regulatory pathway for your product.
  • practical strategies for structuring compliant, submission-ready dossiers - and avoiding the most common pitfalls in your day-to-day work.

Detailed programme

from 9:00 am to 5:00 pm CET - online training
You may dial in 30 minutes before the lecture starts

Welcome, introduction, expectations


Key guidelines and requirements (Focus: EU)
  • Medicinal products: EU GMP Volume 4, Annexes, selected ICH guidelines and more
  • Medical devices: MDR/IVDR and annexes, ISO 13485/ISO 14971, roles and responsibilities, CE marking/EU Declaration of Conformity/UDI
  • Combination products: MDR Article 1 and Article 117, Annex IX, borderline classification rules (Article 2 of Directive 2001/83/EC), EMA 259165/2019, EMA 37991/2019, outlook on FDA (unified approach), COMBO Group

Bio break


Regulatory Affairs I: Marketing authorisation process for medicinal products
  • Procedure types (national, MRP, DCP, CP)
  • Application types (full dossier, generic applications)
  • Marketing authorisation documentation (eCTD)
  • Competent authorities
  • Case study

Regulatory Affairs II: Conformity assessment of medical devices
  • Medical device classification
  • Roles and responsibilities (authorities, notified bodies, European Commission, etc.)
  • Route selection (with or without notified body involvement)
  • Technical documentation: Requirements, risk management, clinical evaluation, etc.
  • QM system as an integral part of device file
  • Intended use and design changes
  • Case study

Lunch break


Documentation strategies using quality related data as a role model
  • Overall concept: Regulatory vs. GMP documentation
  • Identification of relevant GMP data for regulatory purposes
  • Documentation principles (GDocP, ALCOA+ vs. document control)
  • Roles and responsibilities
  • Practical examples: Typical differences in terminology and interpretation
  • Case study: From GMP to regulatory document

Combination products: Regulatory strategy
  • Regulatory distinction: Medicinal products vs. medical devices
  • Primary Mode of Action (PMOA): Definition, regulatory classification (EU vs. US), impact on regulatory strategy
  • Intended use and PMOA: Case examples
  • Regulatory strategy development
  • Responsibility for placing products on the market

Bio break

Combination products: Common pitfalls and solutions
  • Process thinking: Intended use vs. standardised criteria/validated processes
  • Data integrity: ALCOA+ and audit trails
  • Risk management: ICH Q9 vs. ISO 14971
  • Supplier management and supplier risk assessment
  • "Death by Change Control": The risk of product changes for combination products
  • Use of computerised systems and AI (Annex 11, Annex 22)
  • Lifecycle management and product maintenance
  • Inspection readiness and regulatory reality
  • Practical implementation of responsibility demarcation agreements

Case studies/practical workshop
In small groups, participants perform a structured high-level assessment of realistic combination product scenarios using a regulatory decision tree to determine product classification, PMOA, the applicable EU regulatory pathway. Key regulatory risks and uncertainties are then identified and prioritised using a simplified risk matrix. Results are subsequently discussed in a plenary session.

Recap and outstanding questions


End of the seminar


More information

In-house seminars: Advanced training tailor-made!

You are looking for this topic for several employees?
We offer the right solution at your site or in virtual format!

We also offer this seminar as an in-house seminar.

Take advantage of the proven concepts of our open seminars and bring your employees to the same level of knowledge quickly and easily.

We will be happy to send you a non-binding offer.

Technical requirements

You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.

We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.

Access to and procedure for online events

Once you have registered for an event, we will send you the access information for your customer portal. Click here to log in to the customer portal using your email address and password. Please ensure you can access the customer portal before the day of the event.

All important or additional information and personal documents are available in your personalised customer portal. This is also where you start your online courses. If you do not have access to the customer portal yet, you can easily register here.

On the day of the event, you kick off your online training in the customer portal by clicking ‘Participate’ directly in the respective event. You will then be redirected to the Learning Space.

Learn more about our online events here.

Free pre-meeting and technology check

You can attend one of our pre-meetings and explore our Learning Space free of charge. Registration is not required. You can find available dates for a pre-meeting in your customer portal. Click the green ‘Participate’ button in the pre-meeting in the customer portal and you will be redirected to the Learning Space.

The pre-meeting gives you the opportunity to explore our Learning Space and to familiarise yourself with the technology to start off your online training on the right foot. This is a non-binding offer for all our customers and not a prerequisite for participation. If a pre-meeting date does not suit you but you would still like a technology check, please contact us.

This distinguishes our events

of 5 stars of all ratings from 2025

of 5 stars on Trustpilot = good

Recommendations

Global Pharmacovigilance Requirements

Regulatory expectations regarding risk management for pharmaceuticals in (emerging) markets often contend with the strin...

14. - 15.07.2026 in
Details

Artificial Intelligence in Pharmacovigilance

Join our interactive course to explore how AI is transforming pharmacovigilance. Take part in discussions, hands-on work...

21.08.2026 in
Details

The EU Qualified Person for Pharmacovigilance (EU QPPV)

This online two-day course equips new, aspiring, and practising QPPVs with a clear understanding of their role under EU ...

01. - 02.07.2026 in
Details

CMC writing excellence: From development data to CTD content

Would you like to feel more confident presenting your CMC/quality data clearly and in full compliance with regulatory st...

01.07.2026 in
Details

Regulatory Affairs and GMP compliance in Eastern Europe

This online training offers comprehensive insights into Regulatory Affairs, CMC, and GMP requirements, with a focus on t...

26. - 27.08.2026 in
Details

Go forward

In-house seminars

Our programmes are also available for in-house training. Just contact us!

Details
In-house seminars
List of abbreviations pharma & healthcare

Many abbreviations are used in pharma & healthcare. Download the list of the most important ones.

Details
Abbreviations, Glossary
Our rating in 2025

More than 3,700 customers have rated our training courses. Thank you for awarding us 4.4 stars out of 5.

Details
Our rating in 2025